Product Information
Name:PF-06459988
Brand:Biosynth
Description:PF-06459988 is a potent and selective ATP-competitive inhibitor of the epidermal growth factor receptor (EGFR). It is an orally bioavailable small molecule that potently and selectively inhibits EGFR with a binding affinity more than 10,000 times greater than other known kinases. PF-06459988 has shown efficacy in inhibiting the growth of human cancer cells in vitro and in vivo. In addition, it has been shown to inhibit the proliferation of human keratinocytes. PF-06459988 binds to the ATP site on EGFR with higher affinity than ATP, and then undergoes covalent modification of the catalytic domain to form a stable complex. This covalent modification prevents phosphorylation at tyrosine residues by inhibiting protein kinase activity.PF-06459988 has been shown to be well tolerated in Phase 1 clinical studies for patients with advanced solid tumors.
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:431.88 g/mol
Formula:C19H22ClN7O3
Purity:Min. 95%
Technical inquiry about: PF-06459988
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.